MRKR
Marker Therapeutics, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Marker Therapeutics (MRKR) Stock: Buy, Sell, or Hold?
$0.95
0.00 (-0.02%)
âŧ
5d:
-5.93%
30d:
+2.72%
90d:
-14.41%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (83%)
Quality Score
48/100
Position
SLIGHTLY LOW
30-Day Fair Range
$0.91 â $1.07
Position: SLIGHTLY LOW
Forward P/E & Valuation
-1.8x
Next 12M consensus est.
Wall Street Target
$7.87
+728.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.87 / $1.07
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: MRKR is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When MRKR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: MRKR is currently trading at $0.95, which is considered slightly low relative to its 30-day fair value range of $0.91 to $1.07.
Technical Outlook: Technically, MRKR is in a strong downtrend. Immediate support is located at $0.87, while resistance sits at $1.07.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $7.87 (+728.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MRKR is in a strong downtrend. Immediate support is located at $0.87, while resistance sits at $1.07.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $7.87 (+728.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.91 -
$1.07
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Trading Range & Key Levels
30-Day Trading Range
$0.91 -
$1.07
Current vs Trading Range
SLIGHTLY LOW
Support Level
$0.87
Resistance Level
$1.07
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (50/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 728.0% below Wall St target ($7.87)
- WARNING: Composite score 48/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-1.79
Wall Street Target
$7.87
(+728.0%)
Revenue Growth (YoY)
-51.0%
Profit Margin
-245.5%
Share MRKR Analysis
Share this live MRKR analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (MRKR)
Bearish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 5, 2026
Daily AI digest
AI Retail Discussion Summary:
Bearish sentiment dominates $MRKR on StockTwits with one user expressing disappointment in their investment.
Key Retail Themes:
investor regret
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 9:52 PM ET
Data refreshes hourly during market hours. Next update: 10:52 PM
Data refreshes hourly during market hours. Next update: 10:52 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MRKR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals IâĻ |
STRONG BUY
32 analysts |
$592 | 44 HOLD |
|
ALNY
Alnylam Pharmaceuticals âĻ |
STRONG BUY
30 analysts |
$302 | 55 HOLD |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
15 analysts |
$22 | 67 BUY |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$75 | 66 BUY |
|
ASND
Ascendis Pharma AS |
STRONG BUY
21 analysts |
$304 | 34 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive MRKR Research Pages
